Archives
-
Bivalent mRNA Vaccine Against SARS-CoV-2 Variants
2026-09-04
The reference study characterizes RQ3025, a broad-spectrum bivalent mRNA vaccine whose engineered spike sequence incorporates mutations associated with SARS-CoV-2 evolution. Across mouse, hamster, and rat models, RQ3025 induced cross-variant neutralizing antibodies, supported protection in vaccinated rats, promoted a Th1-biased response, and showed no evident organ pathology after high-dose administration.
-
How Cytoskeletal Forces Trigger Autophagy
2026-09-04
Liu et al. show that compression-induced autophagy depends primarily on cytoskeletal microfilaments, while microtubules provide an auxiliary contribution. By combining cytoskeletal polymerization perturbations with fluorescence imaging and immunoblotting, the study links cellular mechanics to autophagosome formation and defines a framework for testing mechanotransduction-dependent stress responses.
-
Aprotinin and RBC Mechanics: Smarter Assay Design
2026-09-03
Aprotinin, or bovine pancreatic trypsin inhibitor, can serve as a reversible perturbation tool for separating protease-dependent effects from intrinsic red blood cell membrane mechanics. This article connects fibrinolysis inhibition with a rigorous interpretation of membrane-bending assays.
-
Cx43/NF-κB Signaling in AngII Macrophage Polarization
2026-09-02
The reference study identifies connexin 43 (Cx43) and NF-κB/p65 signaling as coordinated drivers of Angiotensin II-induced M1-like polarization in RAW264.7 macrophages. Its inhibitor-based design connects Cx43 activity with inflammatory cytokine production and provides a useful framework for studying connexin-dependent immune regulation in cardiovascular inflammation.
-
ROS Measurement as a Radiosensitization Strategy
2026-09-02
Reactive oxygen species are becoming a strategic pharmacodynamic readout in radiosensitization research. This article connects DCFH-DA-based live-cell ROS measurement with recent evidence that BRD4-targeting PROTAC nanoassemblies can amplify FLASH radiotherapy-induced oxidative damage, while outlining validation practices and translational limitations.
-
HOBt in Medicinal Chemistry: Route Design to SAR
2026-09-01
HOBt (1-Hydroxybenzotriazole) is more than a peptide-coupling additive: it can shape route selection, stereochemical control, and medicinal-chemistry assay confidence. This article examines its precise role in an indazole glucagon-receptor-antagonist synthesis and translates that evidence into practical workflow decisions.
-
Estradiol: Receptor Signaling and Research Benchmarks
2026-09-01
Estradiol, also called 17 beta-estradiol, activates ERα and ERβ to regulate genomic and rapid cellular signaling. Recent human-cohort and mouse evidence connects declining estradiol with cardiometabolic and renal risk, while showing that multi-organ protection depends on receptor-linked autophagy.
-
Angiotensin Peptides and SARS-CoV-2 Spike Binding
2026-08-31
A 2025 study shows that naturally occurring angiotensin peptides can modulate SARS-CoV-2 spike-protein binding to host receptors, with especially strong effects observed for AXL and selected truncated or modified peptides. The findings introduce a sequence-sensitive connection between renin–angiotensin biology and viral receptor engagement, while remaining an early biochemical observation rather than evidence of altered infection or clinical disease.
-
3-Deazaneplanocin Assay Workflow Guide
2026-08-31
Build reproducible DZNep experiments by connecting SAHH inhibition, EZH2 depletion, apoptosis, and tumor-initiating cell phenotypes. This workflow also shows how receptor-defined experimental design from breast cancer research can improve interpretation without confusing DZNep with a CHK1 inhibitor.
-
Cimetidine in H2R and BBB Research Workflows
2026-08-30
Cimetidine supports complementary H2 receptor pharmacology, gastrointestinal cancer, and permeability studies when its partial-agonist profile and physicochemical behavior are controlled. A modern LLC-PK1-MOCK/MDR1 workflow adds transporter and lysosomal-trapping checks, helping researchers distinguish true barrier transport from assay artifacts.
-
Baicalein Workflows for Cancer & Inflammation
2026-08-29
Baicalein is a pathway-focused tool for connecting 12-LOX activity with arachidonic acid metabolism, apoptosis, cancer-cell responses, and inflammatory signaling. This practical guide combines solvent handling, paired functional assays, reference-inspired controls, and troubleshooting strategies without overstating evidence from related compounds.
-
Cardiogreen (Indocyanine Green): Facts & Workflows
2026-08-28
Cardiogreen, also called Indocyanine green, is a near-infrared tricarbocyanine dye used for vascular diagnostics and light-activated research. Its rapid plasma-protein binding supports cardiac output measurement, liver blood flow assessment, and ophthalmic angiography, while a documented cell workflow applies it to apoptosis induction in photodynamic therapy.
-
HOBt in Peptide Coupling: Practical Workflows
2026-08-28
HOBt supports high-fidelity amide bond formation by converting activated carboxylic acids into reactive benzotriazolyl intermediates under comparatively mild conditions. This guide translates peptide-coupling principles into practical workflows for difficult small-molecule amides, stereochemically sensitive substrates, and medicinal chemistry programs.
-
Red Blood Cell Membrane Bending Rigidity Explained
2026-08-27
Himbert and colleagues separated the mechanical contribution of the red blood cell cytoplasmic membrane from that of the spectrin cytoskeleton by combining X-ray diffuse scattering, neutron spin-echo spectrometry, and molecular dynamics simulations. They estimated a surprisingly low membrane bending modulus of approximately 4–6 kBT, helping reconcile widely divergent measurements of whole-cell red blood cell mechanics.
-
Captopril Across ACE, Bradykinin, and Assay Design
2026-08-27
Captopril is more than a benchmark ACE inhibitor: it is a useful causal probe for separating angiotensin-processing effects from bradykinin-receptor biology. This article translates ileal peristalsis findings into rigorous assay design while defining the evidence boundaries for hypertension and cancer research.